Emetine Hydrochloride

PreclinicalSmall molecule

JJohns Hopkins University

Emetine Hydrochloride is one of 3 small molecule programs targeting Dengue. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DengueNot yet recruiting

DenguePreclinical

Not yet recruiting

Competition

Competitive Landscape

5 competitors in Dengue

#DrugCompanyPhaseTrials

Biological

NNational Environment Agency, Singapore

Preclinical

2 2

Rden2δ30-7169

NNational Institute of Allergy and Infectious Diseases (NIAID)

Phase 1

1 3

Emetine Hydrochloride

JJohns Hopkins University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2029

PreclinicalRecruiting

Dengue

NCT07016321

Clinical

Trials by Indication[1]

Dengue1 trial

Emetine for Viral Outbreaks: A Phase 2/3 Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Emetine for Dengue Fever (a.k.a. EVOLVE Antiviral Initiative)

Recruiting·JJohns Hopkins University·Preclinical·NCT07016321·600 enrolled

Unspecified1 trial

Evaluating Emetine for Viral Outbreaks (EVOLVE)

Terminated·JJohns Hopkins University·Phase 2/3·NCT05889793·4 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Emetine Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Emetine Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Emetine Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Johns Hopkins University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: JJohns Hopkins University

Emetine Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2029

Trials by Indication[1]

Dengue1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News